BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The Company operates in one business segment namely, development of drug candidates for health solutions.
http://www.bellushealth.com/
Comments
Post a Comment